These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23141946)

  • 21. [Hodgkin lymphomas: current understanding of pathogenesis and pathomorphology].
    Pajor L
    Orv Hetil; 2002 Mar; 143(13):651-61. PubMed ID: 11975042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lineage determination of CD20- B-Cell neoplasms: an immunohistochemical study.
    Chu PG; Loera S; Huang Q; Weiss LM
    Am J Clin Pathol; 2006 Oct; 126(4):534-44. PubMed ID: 16938666
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hodgkin and Reed/Sternberg cell.
    Küppers R; Hansmann ML
    Int J Biochem Cell Biol; 2005 Mar; 37(3):511-7. PubMed ID: 15618006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pitfalls and update in haematopathology. Case 8: angioimmunoblastic T-cell lymphoma].
    Parrens M
    Ann Pathol; 2012 Oct; 32(5):371-6. PubMed ID: 23141947
    [No Abstract]   [Full Text] [Related]  

  • 25. Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Rysenga E; Linden MD; Carey JL; Ross CW; Schnitzer B; Sawdyk M; Maeda K
    Arch Pathol Lab Med; 1995 Jan; 119(1):88-91. PubMed ID: 7802562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of Oct2 and its significance in lymphoma diagnosis].
    Zhao XR; Ma DL
    Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):337-40. PubMed ID: 16185500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen.
    Harada S; Kalla H; Balasubramanian M; Brodsky I; Gladstone D; Hou JS
    Ann Diagn Pathol; 2008 Jun; 12(3):212-6. PubMed ID: 18486899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does "in situ lymphoma" occur as a distinct step in the development of nodular lymphocyte-predominant Hodgkin lymphoma?
    Carbone A
    Cancer; 2012 Jan; 118(1):15-6. PubMed ID: 21732334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases.
    Tzankov A; Zimpfer A; Pehrs AC; Lugli A; Went P; Maurer R; Pileri S; Dirnhofer S
    Mod Pathol; 2003 Nov; 16(11):1141-7. PubMed ID: 14614054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
    Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
    Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early lesions in lymphomas of germinal centre B-cell derivation: evidence and hypotheses.
    Carbone A; Du MQ; Santoro A; Gloghini A
    J Clin Pathol; 2012 Oct; 65(10):955-8. PubMed ID: 22718842
    [No Abstract]   [Full Text] [Related]  

  • 32. Hodgkin lymphoma classification: Are we at a crossroads?
    Carbone A; Gloghini A
    Cancer; 2017 Oct; 123(19):3654-3655. PubMed ID: 28621881
    [No Abstract]   [Full Text] [Related]  

  • 33. Nodular lymphocyte-predominant hodgkin lymphoma.
    Tsai HK; Mauch PM
    Semin Radiat Oncol; 2007 Jul; 17(3):184-9. PubMed ID: 17591565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-transplant lymphoproliferative disorder with Hodgkin's lymphoma and large B-cell lymphoma differentiation.
    Novoa-Takara L; Dincer A; Kampalath B; Van Tuinen P; Hariharan S; Chang C
    Histopathology; 2005 Sep; 47(3):333-4. PubMed ID: 16115242
    [No Abstract]   [Full Text] [Related]  

  • 37. Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma.
    Tedoldi S; Mottok A; Ying J; Paterson JC; Cui Y; Facchetti F; van Krieken JH; Ponzoni M; Ozkal S; Masir N; Natkunam Y; Pileri S; Hansmann ML; Mason D; Tao Q; Marafioti T
    J Pathol; 2007 Dec; 213(4):429-40. PubMed ID: 17935142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating germinal center-derived lymphomas through their cellular microenvironment.
    Carbone A; Gloghini A; Cabras A; Elia G
    Am J Hematol; 2009 Jul; 84(7):435-8. PubMed ID: 19484731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies.
    Chan WC
    Semin Hematol; 1999 Jul; 36(3):242-52. PubMed ID: 10462324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The importance of follow-up biopsies of clinically suspicious lymphadenopathy in nodular lymphocyte predominant Hodgkin's lymphoma.
    Achten R; Verhoef G; De Wolf-Peeters C
    Haematologica; 2003 Dec; 88(12):1431-2. PubMed ID: 14688002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.